| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |